ArticlePharmacoEconomics2023

Modeling Monthly Migraine-Day Distributions Using Longitudinal Regression Models and Linking Quality of Life to Inform Cost-Effectiveness Analysis: A Case Study of Fremanezumab in Japanese-Korean Migraine Patients.

Xinyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.